Terrell Hogan Law Logo
Call Now for a Free
Queremos Ayudarle
Incretin Mimetic Drugs for Type 2 Diabetes Linked to Pancreatitis

There is evidence that incretin mimetic drugs for Type 2 Diabetes may lead to pancreatitis. In fact, in 2014, the FDA required this fact to be stated on warning labels. A study has shown that chronic pancreatitis increases the risk of pancreatic cancer by nearly eight times.

What Are Incretin Mimetic Drugs?

Incretin mimetics are a relatively new group of injectable drugs for type 2 diabetes treatment. They are a type of medication that mimics the incretin hormones our body naturally produces after a meal to aid the hormone insulin help our body’s cells take up glucose to use for energy. Incretin mimetics (such as Exenatide (BYETTA), Liraglutide (VICTOZA), Sitagliptin (JANUVIA and JANUMET), Linagliptin, Saxagliptin, and Vildagliptin) are second-line medications and have been prescribed when first-line of medications (such as Metformin, Sulfonylureas, and Meglitinides), diet, exercise, and weight loss fail to bring a patient’s blood glucose levels into normal range. Incretin Mimetics medications work by:

  • Increasing the body’s production of natural insulin, and
  • Suppressing glucagon secretion, the hormone that causes the liver to release stored glucose and increase blood sugar.

Past Concerns

A 2009 study of deceased human organ donors found that incretin therapy acted as a growth hormone, making pancreatic cells multiply, fueling the growth of precancerous lesions.

Findings from studies conducted by Johns Hopkins University School of Medicine showing that Incretin medications lead to an increased risk of pancreatitis, pre-cancerous cellular changes (pancreatic duct metaplasia), and pancreatic cancer has been under investigation by the FDA since 2013.


Get Help Now

Fill this out for a FREE case review.

Briefly type in what happened.
That’s all it takes to start the conversation, and, together, we will decide if Terrell • Hogan is the injury and wrongful death law firm to help you.
Sending your message means you are familiar with the purpose of this website.

This field is for validation purposes and should be left unchanged.

About The Author

Picture of Leslie A. Goller

Leslie A. Goller

Leslie has dedicated her career to championing consumers – whether they were harmed by big corporations, dangerous products, medical mistakes, accidents, or an unsafe environment – no issue is too big for her to tackle. She successfully prevented an incinerator from being built at University Hospital (now UF-Jacksonville), which would have polluted the air with toxic chemicals and obtained significant restrictions of other Jacksonville hospital incinerators resulting in cleaner air.